NYSEMKT: TOVX
Theriva Biologics Inc Stock Ownership - Who owns Theriva Biologics?

Insider buying vs selling

Have Theriva Biologics Inc insiders been buying or selling?

No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when TOVX insiders and whales buy or sell their stock.

TOVX Shareholders

What type of owners hold Theriva Biologics Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Steven A. Shallcross2.60%250,000$80.00kInsider
Ikarian Capital LLC1.25%120,031$38.41kInstitution
Citadel Advisors LLC0.38%36,018$11.53kInstitution
Boothbay Fund Management LLC0.37%35,601$11.39kInstitution
Virtu Financial LLC0.36%34,495$11.04kInstitution
Geode Capital Management LLC0.19%18,601$5.95kInstitution
Two Sigma Securities LLC0.19%17,818$5.70kInstitution
Xtx Topco Ltd0.18%17,187$5.50kInstitution
Blackrock Inc0.08%7,568$2.42kInstitution
Fmr LLC0.03%3,000$960.00Institution

1 of 2

TOVX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
TOVX3.03%2.60%
NLSP3.88%0.00%
MLEC0.00%86.24%
ELAB0.11%99.89%
VRAX0.81%0.00%

Theriva Biologics Stock Ownership FAQ

Who owns Theriva Biologics?

Theriva Biologics (NYSEMKT: TOVX) is owned by 3.03% institutional shareholders, 2.60% Theriva Biologics insiders, and 94.36% retail investors. Steven A. Shallcross is the largest individual Theriva Biologics shareholder, owning 250,000.00 shares representing 2.60% of the company. Steven A. Shallcross's Theriva Biologics shares are currently valued at $78.00k.

If you're new to stock investing, here's how to buy Theriva Biologics stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.